This is a Technicum podcast. There is a digital transformation all around us. We know this from news reports, but even more so, we know this because we are a part of it. How many of your daily activities are done on your computer or mobile telephone? So what about the big picture, like treating cancer in children?

How has this changed for the better in our digital world?

I'm Peter Balland from Technicon, and today we explore this very topic with

David Charillo from the IPC project.

He represents the Barcelona Supercomputing Center, a partner in IPC,

which, by the way, stands for individualized pediatric cure. Doctors, clinicians, oncologists,

biomedical engineers, and computer scientists are working together in IPC to use data, human samples,

and artificial intelligence to tailor treatments for kids while

minimizing the risks. Let's have a listen.

Thanks David Day for coming on today. Thank you. Thank you. It's a pleasure to be here. Thank you

for having me. First, let's look at what IPC is trying to do. But frame your answer around this quote, and this is from the IPC webpage.

The future of pediatric cancer treatment is in personalization.

Yes. So in this sentence, there are two words that really stands out and really like

summarize very well the goals of the IPC projects. And those words are personalization and

future. So in the health domain, by personalization, we generally refer to personalized medicine,

which is a medical paradigm centered around the patient,

so in order to deliver better therapeutic strategies and preventive solutions.

So have you ever noticed that if you have two patients that have been

diagnosed with the same condition and you give exactly the same treatment to them, the outcome

of this treatment will be different. So maybe like in one of two people that the drug is used is working very well, but the other

is maybe not working very much.

So the reason behind this is that the variability in the human population is huge.

...